(NMR) Nomura Holdings - Ratings and Ratios

Exchange: NYSE • Country: Japan • Currency: USD • Type: Common Stock • ISIN: US65535H2085

NMR: Investment, Management, Securities, Trading, Financing, Advisory

Nomura Holdings Inc ADR (NYSE:NMR) is a global financial powerhouse with a rich history dating back to 1925. Headquartered in Tokyo, Japan, Nomura operates as a full-service financial institution, catering to a diverse clientele that includes individuals, corporations, financial institutions, governments, and governmental agencies. The company is listed on the NYSE under the ticker symbol NMR and falls under the GICS Sub Industry of Investment Banking & Brokerage.

Nomura’s business is organized into three core segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management division provides tailored financial products and investment consultation services, designed to meet the unique needs of high-net-worth individuals and other affluent clients. The Investment Management segment focuses on managing investment trusts, offering discretionary investment services, and operating investment funds, leveraging Nomura’s deep expertise in global markets to deliver value to its clients.

The Wholesale segment is the backbone of Nomura’s operations, engaging in a wide array of activities such as the sale, trading, and market-making of fixed income and equity products. This segment also specializes in structured finance solutions, underwriting various securities, and arranging private placements. Additionally, Nomura provides financial advisory services on complex business transactions, including mergers and acquisitions, corporate restructuring, and leveraged buyouts, positioning itself as a trusted partner for corporations navigating intricate financial landscapes.

With a market capitalization of $20.249 billion, Nomura is a significant player in the global financial services industry. The company’s current P/E ratio of 9.67 and forward P/E of 16.08 reflect its strong earnings performance and future growth expectations. The price-to-book (P/B) ratio of 0.85 indicates that the company’s stock may be undervalued relative to its book value, making it an attractive proposition for value investors. The price-to-sales (P/S) ratio of 0.01 highlights Nomura’s ability to generate revenue efficiently, a critical metric for investors evaluating the company’s operational performance.

Nomura’s global network and extensive experience in both developed and emerging markets make it a key player in cross-border transactions. Its commitment to innovation and digital transformation has enabled the company to stay ahead of the curve in a rapidly evolving financial landscape. For investors and fund managers, Nomura’s diversified business model, strong market position, and track record of resilience through economic cycles make it a compelling investment opportunity in the financial services sector.

Additional Sources for NMR Stock

NMR Stock Overview

Market Cap in USD 20,046m
Sector Financial Services
Industry Capital Markets
GiC Sub-Industry Investment Banking & Brokerage
IPO / Inception 1961-10-01

NMR Stock Ratings

Growth 5y 24.9%
Fundamental -
Dividend 4.35%
Rel. Strength Industry -10.5
Analysts 3/5
Fair Price Momentum 6.23 USD
Fair Price DCF -

NMR Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 71.7%

NMR Growth Ratios

Growth Correlation 3m 52.9%
Growth Correlation 12m -4.4%
Growth Correlation 5y 31.7%
CAGR 5y 8.84%
CAGR/Max DD 5y 0.17
Sharpe Ratio 12m 0.44
Alpha -14.92
Beta 1.60
Volatility 27.53%
Current Volume 336.3k
Average Volume 20d 612k
What is the price of NMR stocks?
As of February 23, 2025, the stock is trading at USD 6.48 with a total of 336,283 shares traded.
Over the past week, the price has changed by -4.14%, over one month by +5.88%, over three months by +7.11% and over the past year by +16.34%.
Is Nomura Holdings a good stock to buy?
Neither. Based on ValueRay Analyses, Nomura Holdings is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.86 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NMR as of February 2025 is 6.23. This means that NMR is currently overvalued and has a potential downside of -3.86%.
Is NMR a buy, sell or hold?
Nomura Holdings has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold NMR.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for NMR stock price target?
According to ValueRays Forecast Model, NMR Nomura Holdings will be worth about 6.7 in February 2026. The stock is currently trading at 6.48. This means that the stock has a potential upside of +3.86%.
Issuer Forecast Upside
Wallstreet Target Price 7.2 10.8%
Analysts Target Price 6.2 -4.3%
ValueRay Target Price 6.7 3.9%